An International, Open Label, Randomised Controlled Trial Comparing Rituximab With Azathioprine as Maintenance Therapy in Relapsing ANCA-associated Vasculitis
Latest Information Update: 28 Mar 2023
At a glance
- Drugs Rituximab (Primary) ; Azathioprine; Glucocorticoids; Methotrexate; Methotrexate; Methotrexate; Mycophenolate mofetil
- Indications Anti-neutrophil cytoplasmic antibody-associated vasculitis
- Focus Registrational; Therapeutic Use
- Acronyms RITAZAREM
- 23 Mar 2023 Results published in the Annals of the Rheumatic Diseases.
- 06 Jun 2020 Results assessing effect of rituximab from this study, presented at the 21st Annual Congress of the European League Against Rheumatism
- 27 Feb 2020 Status changed from active, no longer recruiting to completed.